Pharmafile Logo

initiative

- PMLiVE

Galderma’s Nemluvio shows sustained improvements in moderate-to-severe atopic dermatitis

Up to 91% of patients achieved at least 75% improvement in eczema severity and up to 67% achieved near-complete skin clearance

Literature review webinar promo

Join Genesis Research Group’s October webinar: ‘From scoping to systematic: Choosing the right literature review for your evidence needs’.

On Tuesday, 6 October 2026, Genesis Research Group’s evidence synthesis, HEOR, and evidence planning teams will be presenting an expert webinar on the topic of selecting the right literature review.

Genesis Research Group

- PMLiVE

Inizio Evoke appoints Barbara Patchefsky as Global Client Lead

Patchefsky most recently served as Global Client Director at Havas Health & You

- PMLiVE

Using AI Responsibly in CME Outcomes Reporting

ICYMI at #AIS2026: using AI in outcomes reporting is a lot like onboarding a research assistant. There's real efficiency in having the help, and a significant amount of background teaching,...

Medscape Education

- PMLiVE

ANTHEM launches Healthy Influence – a new science-led approach to solve healthcare’s attention problem

Global healthcare communications consultancy ANTHEM, a Resonant Group company, today announces the launch of Healthy Influence™, its proprietary methodology that applies the science of influence to healthcare communications.

Resonant Group

- PMLiVE

MSD announces phase 2 results for tulisokibart in moderate to severe hidradenitis suppurativa

Tulisokibart was designed to help address immuno-fibrosis, a key driver of disease progression in HS

- PMLiVE

Inizio Evoke appoints Brian Gundich as EVP, AI Enablement

Gundich most recently drove enterprise-wide intelligence and operations transformations at Interpublic Group

- PMLiVE

Roche’s fenebrutinib receives FDA filing acceptance for relapsing and primary progressive MS

If approved, this treatment would offer a new option for the nearly one million Americans living with MS

- PMLiVE

Inizio Evoke appoints Jake Vander Linden as President, Media

Vander Linden was previously EVP, Innovation and Advanced Agitation at Moon Rabbit

Patient speaking to doctor

The outcomes are already chosen. So when can patients really shape them?

Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.

Cuttsy + Cuttsy

- PMLiVE

Ogsiveo recommended by NICE to treat rare soft tissue tumours

Desmoid tumours are rare soft tissue tumours that can grow aggressively into nearby tissues

- PMLiVE

Heart, humanity and the work behind the words

What makes a great healthcare communicator in an age when technology can write, analyse and create content in seconds?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links